Clinical Trial Update: TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating TCR alpha/beta depletion for hematopoietic stem cell transplantation from haploidentical and unrelated donors in primary immune defic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Transplantation
• Immune Deficiency Disorders

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: Primary Immune Deficiency Disorder, Hematopoietic Stem Cell Transplantation | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-02-26